These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636 [TBL] [Abstract][Full Text] [Related]
6. RabGEF1, a negative regulator of Ras signalling, mast cell activation and skin inflammation. Tam SY; Kalesnikoff J; Nakae S; Tsai M; Galli SJ Novartis Found Symp; 2005; 271():115-24; discussion 124-30, 145-51. PubMed ID: 16605131 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482 [TBL] [Abstract][Full Text] [Related]
8. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor. Samayawardhena LA; Hu J; Stein PL; Craig AW Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778 [TBL] [Abstract][Full Text] [Related]
9. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Tam SY; Tsai M; Snouwaert JN; Kalesnikoff J; Scherrer D; Nakae S; Chatterjea D; Bouley DM; Galli SJ Nat Immunol; 2004 Aug; 5(8):844-52. PubMed ID: 15235600 [TBL] [Abstract][Full Text] [Related]
10. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor. Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052 [TBL] [Abstract][Full Text] [Related]
11. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases. Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931 [TBL] [Abstract][Full Text] [Related]
13. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Feuser K; Feilhauer K; Staib L; Bischoff SC; Lorentz A Mol Immunol; 2011 Jan; 48(4):546-52. PubMed ID: 21106245 [TBL] [Abstract][Full Text] [Related]
14. Differential release of mast cell interleukin-6 via c-kit. Gagari E; Tsai M; Lantz CS; Fox LG; Galli SJ Blood; 1997 Apr; 89(8):2654-63. PubMed ID: 9108382 [TBL] [Abstract][Full Text] [Related]
15. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells. Shivakrupa R; Linnekin D Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030 [TBL] [Abstract][Full Text] [Related]
16. RIN3 is a negative regulator of mast cell responses to SCF. Janson C; Kasahara N; Prendergast GC; Colicelli J PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384 [TBL] [Abstract][Full Text] [Related]
17. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Galli SJ; Tsai M; Wershil BK Am J Pathol; 1993 Apr; 142(4):965-74. PubMed ID: 7682764 [TBL] [Abstract][Full Text] [Related]
18. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit. Iwaki S; Tkaczyk C; Satterthwaite AB; Halcomb K; Beaven MA; Metcalfe DD; Gilfillan AM J Biol Chem; 2005 Dec; 280(48):40261-70. PubMed ID: 16176929 [TBL] [Abstract][Full Text] [Related]